Cerebral Infarction
The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
Subtype terms (5)
More specific conditions that are subtypes of Cerebral Infarction in the MeSH hierarchy.
- CADASIL
9 drugs (6 approved, 3 experimental)
- Dementia, Multi-Infarct
- Infarction, Anterior Cerebral Artery
3 drugs (2 approved, 1 experimental)
- Infarction, Middle Cerebral Artery
17 drugs (9 approved, 8 experimental)
- Infarction, Posterior Cerebral Artery
2 drugs experimental
Drugs by status
Approved for this indication (2)
Phase 4 trials (20)
Phase 3 trials (18)
Phase 2 trials (14)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (123)
- Eisai
- Merck
- Pfizer
- Sanofi
- Ever Neuro Pharma GmbH
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Techpool Bio-Pharma Co., Ltd.
- Accumetrics, Inc.
- Boehringer Ingelheim
- Otsuka
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Cerebral and Cardiovascular Center
- National Institute of Neurological Disorders and Stroke (NINDS)
- Huazhong University of Science and Technology
- ShuGuang Hospital
- Ajou University
- Central South University
- Hebei University
- Anhui Medical University
- Cathay General Hospital
- Chang Gung University
- Changhua Christian Hospital
- Chung Shan Medical University
- Clinical Institute of the Brain, Russia
- Chimei Medical Center
- China Academy of Chinese Medical Sciences
- Fengtian Hospital
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Guangxi Medical University
- Guangzhou Medical University
- +93 more
Organization Involved with Phase 3 Indications (72)
- Pierre Fabre
- Bristol-Myers Squibb
- Cerevast Therapeutics, Inc.
- Ferrer Internacional S.A.
- Hamilton Health Sciences Corporation
- Materia Medica Holding
- Neurobiological Technologies
- Simcere Pharmaceutical Co., Ltd
- Tasly Pharmaceuticals, Inc.
- D-Pharm Ltd.
- Dexa Medica Group
- NoNO Inc.
- Pharmazz, Inc.
- Japan Cardiovascular Research Foundation
- Fundacion Clinic per a la Recerca Biomédica
- Haukeland University Hospital
- Ain Shams University
- CHIMES Society
- Chulalongkorn University
- Emory University
- Gadjah Mada University
- McMaster University
- Ohio State University
- Tokyo Women's Medical University
- University Hospital of North Norway
- University of Heidelberg
- University of Miami
- University of Toronto
- Utrecht University
- University of Alberta
- +42 more
Organization Involved with Phase 2 Indications (117)
- ZZ Biotech, LLC
- AbbVie
- Acorda Therapeutics
- ImaRx Therapeutics
- Daiichi Sankyo
- Green Cross Corporation
- Mitsubishi
- Biogen
- AZTherapies, Inc.
- Aldagen
- Athersys, Inc
- Bayer
- CHABiotech CO., Ltd
- DiaMedica USA Inc.
- GNT Pharma
- Jeil Pharmaceutical Co., Ltd.
- M's Science Corporation
- Prolong Pharmaceuticals
- SanBio, Inc.
- Sclnow Biotechnology Co., Ltd.
- Sygnis Bioscience GmbH & Co KG
- Techfields
- Sunovion
- Thrombotech Ltd.
- Moleac Pte Ltd.
- ReNeuron Limited
- National Institutes of Health (NIH)
- José Castillo, M.D.
- Kyunghee University Medical Center
- The University of Texas Health Science Center, Houston
- +87 more
Organization Involved with Phase 1 Indications (17)
- CSL Behring
- Translational Sciences, Inc.
- China Spinal Cord Injury Network
- Dow University of Health Sciences
- Mazandaran University of Medical Sciences
- Postgraduate Institute of Medical Education and Research
- University of Kentucky
- Chinese University of Hong Kong
- City University of Hong Kong
- The University of Hong Kong
- BioVision, Inc.
- Inova Health System
- Dr. Jeffrey Thomas Stroke Shield Foundation
- StemCyte, Inc.
- Johnson and Johnson
- Meridigen Biotech Co., Ltd.
- Mononuclear Therapeutics Ltd.
Organization Involved with Other Experimental Indications (21)
- Genentech
- General Hospital of Shenyang Military Region
- Dongfang Hospital Beijing University of Chinese Medicine
- Centre Hospitalier St Anne
- Gachon University
- Newcastle University
- University of Edinburgh
- University of Lausanne
- University of Bern
- University of Cambridge
- Xingtai People's Hospital
- University of Montpellier
- Centre Hospitalier Sainte-Anne
- University of North Carolina at Chapel Hill
- Universitaetsklinikum Schleswig-Holstein
- Changchun University of Chinese Medicine
- Shunyi Hospital of Traditional Chinese Medicine
- Huairou Hospital of Traditional Chinese Medicine
- Wuqing Hospital of Traditional Chinese Medicine
- University of Burgundy
- Imperial College London